Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
GlucoTrack ( (GCTK) ) just unveiled an update.
Glucotrack, Inc. recently concluded a $10 million public offering and a concurrent private placement converting $4 million of outstanding debt into equity. The offering involved shares, pre-funded warrants, and series A and B common warrants, with proceeds earmarked for working capital and corporate purposes. The company aims to meet Nasdaq’s stockholders’ equity requirements, crucial for maintaining its listing. This strategic move highlights Glucotrack’s commitment to advancing its pioneering diabetes technologies while addressing financial compliance challenges.
Find detailed analytics on GCTK stock on TipRanks’ Stock Analysis page.
